Sk Pharmteco
Sk Pharmteco, a leading contract development and manufacturing organisation (CDMO), is headquartered in the United States and operates across key regions including Europe and Asia. Founded in 2017, the company has rapidly established itself in the pharmaceutical industry, specialising in the development and production of complex drug substances and advanced therapies. With a focus on small molecules, biologics, and cell and gene therapies, Sk Pharmteco offers unique solutions that cater to the evolving needs of its clients. The company is recognised for its state-of-the-art facilities and commitment to quality, which have positioned it as a trusted partner for pharmaceutical companies worldwide. Notable achievements include significant expansions and strategic partnerships that enhance its capabilities and market reach.
DitchCarbon Score
How does Sk Pharmteco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sk Pharmteco's score of 8 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sk Pharmteco's reported carbon emissions
As of the latest available data, SK Pharmteco has not publicly reported specific carbon emissions figures in kg CO2e. However, the company has made significant climate commitments, including a pledge to achieve net-zero emissions across all scopes by 2050. This commitment was formalised in 2023, indicating a long-term strategy to address climate change within the pharmaceutical, biotechnology, and life sciences sector. SK Pharmteco is actively engaged in the Science Based Targets initiative (SBTi), demonstrating its commitment to aligning with global climate goals. The company is currently in the process of establishing near-term reduction targets, with a focus on comprehensive emissions management across its operations. While specific reduction targets and achievements have not been disclosed, SK Pharmteco's commitment to net-zero emissions reflects a proactive approach to sustainability and environmental responsibility in the United States.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sk Pharmteco is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
